UNCONVENTIONAL INNOVATIONS PROGRAM Release Date: September 4, 1998 P.T. National Cancer Institute The National Cancer Institute (NCI) announces the creation of the Unconventional Innovations Program (UIP) to fund the development of high impact, long-range technologies to support cancer research. Initial plans target $48 million in the UIP over the next 5 years for technology platforms to enable integration of: o non-invasive sensing of molecular alterations in vivo o transmission of molecular information to an external monitor o controlled intervention specific for the molecular profile o monitoring of intervention The NCI is soliciting input from researchers about technologies that could fundamentally change the approach to the detection, diagnosis, and treatment of cancer. Submitted information will help define the general scope of a Broad Agency Announcement to fund research that will be issued in late 1998 or early 1999. Ideas are requested in the form of white papers, which address: o nature of the technological opportunity o current capability of the technology o technological barriers to meeting the defined goal o contribution to the opportunity for the non-intrusive sensing, signaling, and intervention for cancer based on tumor specific molecular profiles o potential impact on the detection, diagnosis, and treatment of cancer INQUIRIES For further information and guidance see: http://amb.nci.nih.gov/ For programmatic issues contact: Carol Dahl, Ph.D. Office of Technology and Industrial Relations National Cancer Institute 31 Center Drive, Room 11A03, MSC 2590 Bethesda, MD 20892-2590 Telephone: (301) 496-1550 FAX: (301) 496-7807 Email: carol_dahl@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |